期刊文献+

内皮抑素基因逆病毒载体的构建及其在白血病细胞中的表达 被引量:2

Construction of retroviral vector encoding secretable endostatin and its expression in leukemia cells
下载PDF
导出
摘要 目的 探究内皮抑素基因转移在白血病抗血管新生治疗中的价值。方法 构建分泌型内皮抑素的表达载体,联合脂质体转染与交互感染建立逆病毒介导的内皮抑素基因转移系统,并用内皮抑素病毒分别感染白血病细胞WEHI-3B和K562;用聚合酶链反应(PCR)检测靶细胞中内皮抑素基因的整合与表达。结果 脂质体转染与交互感染策略分别获得单嗜型(GP+E-86/ES)和双嗜型(Am12/ES)病毒生产细胞,后者上清的病毒滴度约为7.8×105CFU/ml;内皮抑素病毒感染、G418选择得到内皮抑素基因修饰的WEHI-3B细胞和K562细胞,PCR分析显示两者均有内皮抑素基因整合并持续表达。结论 逆病毒载体有效介导白血病细胞表达内皮抑素,可用于血液肿瘤的血管抑制基因疗法研究。 Objective To investigate the antiangiogenic effect of secretable endostatin gene transfer in leukemia. Methods The gene encoding human secretable endostatin was cloned into retro-viral vector LXSN to generate the vector LESSN. A system for retroviral-mediated endostatin gene transfer was developed by liposome-mediated vector transfection followed with cross infection. Then, leukemia cell WEHI-3BC mouse) and K562(human)were transduced with retrovirus containing LESSN vector. The integration and expression of the external endostatin gene in target cells was analyzed with polymerase chain reaction(PCR). Results Ecotropic GP+E-86/ES and amphotropic Am12/ES retro-viral producer cells were obtained by liposome transfection or superinfection,respectively. The titer of LESSN retrovirus in supernatants from Aml2/ES cells was 7. 8 × 105CFU/ml,approximately. After retroviral transduction followed by G418 selection, endostatin-expressed leukemic cells, e. g. , WEHI-3B/ES cells and K562/ES cells, were gained, in which the integration and durative expression of endostatin gene was confirmed by PCR assay. Conclusion Retroviral-mediated overexpression of secret-able endostatin in leukemic cells may have the potential for examining the angiostatic gene therapy of hematopoietic malignancies.
机构地区 [ 法国INSERM U
出处 《江苏医药》 CAS CSCD 北大核心 2003年第4期263-265,共3页 Jiangsu Medical Journal
基金 江苏省科技厅社会发展基金(BS2001070)
关键词 内皮抑素 逆病毒载体 白血病 血管新生 基因疗法 Endostatin Retroviral vector Leukemia Angiogenesis Gene therapy
  • 相关文献

参考文献10

  • 1[1]Hussong JW,Rodgers GM,Shami PJ.Evidence of increased angiogenesis in patients with acute myeloid leukemia.Blood,2000,95:309-313.
  • 2[2]OReilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 3傅建新,王玮,卢大儒,岑建农,陈子兴.增强型绿色荧光蛋白逆转录病毒载体的构建和表达[J].中国实验血液学杂志,2000,8(4):261-265. 被引量:9
  • 4[4]Keyhani A,Jendiroba DB,Freireich EJ.Angiogenesis and leukemia.Leuk Res,2001,25:639-645.
  • 5[5]Kini AR,Peterson LC,Tallman MS.Angiogenesis in acute promyelocytic leukemia:induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid.Blood,2001,97:3919-3924.
  • 6[6]Rosen L.Antiangiogenic strategies and agents in clinical trials.Oncologist,2000,5(Suppl 1):20-27.
  • 7[7]Iversen PO,Sorensen DR,Benestad HB.Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias.Leukemia,2002,16:376-381.
  • 8[8]Scappaticci FA,Smith R,Pathak A,et al.Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.Mol Ther,2001,3:186-196.
  • 9[9]Eisterer W,Jiang X,Bachelot T,et al.Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia.Mol Ther,2002,5:352-359.
  • 10[10]Lai R,Estey E,Shen Y,et al.Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.Cancer,2002,94:14-17.

二级参考文献14

  • 1DunbarCE,YoungNS.Genemarkingandgenetherapydirectedatprimaryhematopoieticcells.CurrOpinHematol,1996;3:430-437
  • 2KumeA,HanazonoY,MizukamiH,etal.Hematopoieticstemcellgenetherapy:acurrentoverview.IntJHematol,1999;69:227-233
  • 3ChalfieM,TuY,EuskirchenG,etal.Greenfluorescentproteinasamarkerforgeneexpression.Science,1994;263:802-805
  • 4LimonA,BrionesJ,PuigT,etal.High-titerretroviralvectorscontainingtheenhancedgreenfluorescentproteingeneforefficientexpressioninhematopoieticcells.Blood,1997;90:3316-3321
  • 5FuJX,ChenZX,CenJN,etal.Highefficiencyretrovirus-mediatedgenetransfertoleukemiacells.ChinJCancerRes,1999;11:8-12
  • 6FuJX,WangW,RuanCG,etal.Efficientexpressionofhumanmultidrugresistance1genemediatedbyretroviralvectorcontaininginternalribosomalentrysite.中国实验血液学杂志,1999;7:198-204
  • 7PersonsDA,AllayJA,AllayER,etal.Retroviral-mediatedtransferofthegreenfluorescentproteingeneintomurinehematopoieticcellsfacilitatesscortingandselectionoftransducedprogenitorsinvitroandidentificationofgeneticallymodifiedcellsinvivo.Blood,1997;90:1777-1786
  • 8MascarenhasL,StripeckeR,CaseSS,etal.GenedeliverytohumanB-precursoracutelymphoblasticleukemiacells.Blood,1998;92:3537-3545
  • 9DietzAB,Vuk-PavlovicS.Highefficiencyadenovirusmediatedgenetransfertohumandendriticcells.Blood,1998;91:392-398
  • 10ChenWY,BaileyEC,McCuneSL,etal.Reactivationofsilenced,virallytransducedgenebyinhibitorsofhistonedeacetylase.ProcNatlAcadSciUSA,1997;94:5798-5803

共引文献8

同被引文献8

  • 1Folkman J. Tumor angiogenesis:therapeutic implications. N Engl J Med, 1971, 285:1182-1186.
  • 2Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science, 2001,293:293-297.
  • 3Gorski DH, Mauceri HJ, Salloum RM, et al. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin . Cancer Res,1998, 58 :5686-5689.
  • 4Griscelli F, Li H, Cheong C, et al. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci U S A, 2000, 97: 6698-6703.
  • 5Shi W, Teschendorf C, Muzyczka N, et al. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiother Oncol, 2003,66:1-9.
  • 6Weidner N. Intratumor microvessel density as a prognostic factor in cancer .Am J Pathol ,1995 ,147 :9-19.
  • 7O′Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88:277-285.
  • 8王成伟,庞琦,张庆林.抗肿瘤血管生成及其基因治疗[J].癌症,2001,20(10):1109-1111. 被引量:2

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部